Visceral fat area loss reduces 10-year atherosclerotic cardiovascular disease risk in Chinese population with type 2 diabetes mellitus: a prospective cohort study
Jing Jin(University of Science and Technology of China), Xiaohong Wu(Soochow University), Ye Hu(Zhejiang Provincial People's Hospital), Lei Yu(University of Science and Technology of China), Shuning Liu(East China University of Science and Technology), Linna Chen(Zhejiang Provincial People's Hospital), Jia Zheng(Zhejiang Provincial People's Hospital), Jinjian Xu(Zhejiang Normal University), Chenyan Yan(Zhejiang Provincial People's Hospital), Xingyue Cao(Jiangsu Province Hospital)
Cited by 2
Related Papers
Toripalimab Plus Chemotherapy for Patients With Treatment-Naive Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase III Trial (CHOICE-01)
|Journal of Clinical Oncology|2022|177
Ultrasensitive sensors reveal the spatiotemporal landscape of lactate metabolism in physiology and disease
|Cell Metabolism|2022|130
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
|Nature Medicine|2024|121
Hyperuricemia as an Independent Predictor of Vascular Complications and Mortality in Type 2 Diabetes Patients: A Meta-Analysis
|PLoS ONE|2013|108
Sesamin Enhances Nrf2-Mediated Protective Defense against Oxidative Stress and Inflammation in Colitis via AKT and ERK Activation
|Oxidative Medicine and Cellular Longevity|2019|106